Clinical Trial Update: Concurrent Radiotherapy and/or Cisplatin With or Without Celecoxib in Patients With Primary Oral Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating concurrent radiotherapy and/or cisplatin with or without celecoxib for oral squamous cell carcinoma; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Oral Squamous Cell Carcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Celecoxib (Celecoxib)

Snippet

Sponsor: China Medical University Hospital | Conditions: Oral Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN